Cervical Cancer Immunotherapy includes Immune modulators, vaccines, T-cell therapy and monoclonal antibodies. HPV, E6 and E7 oncoproteins are target antigens in immunotherapy of cervical cancer.
Dendritic cells (DC) based immunotherapy is the recent approach in this therapy where dendritic cells are capable of inducing T cells. It is one of the known and major type of cancer for which new immune-based cancer treatments are currently in development.
Related Journals of Cervical Cancer Immunotherapy
Immunotherapy:Open Access, Immunology Journal, Immunobiology journal, Immunome Research journal, Immunooncology journal, New Journal of Science, Journal of Clinical Oncology, American Journal of Hematology / Oncology, Journal of Immunotherapy of Cancer, Journal of Experimental & Clinical Cancer Research.
